Literature DB >> 8896895

Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone.

M H Gail1, T R Fears, R N Hoover, D W Chandler, J L Donaldson, M B Hyer, D Pee, W V Ricker, P K Siiteri, F Z Stanczyk, J B Vaught, R G Ziegler.   

Abstract

We conducted studies to measure sources of assay variability for estrone, estradiol, estrone sulfate, and progesterone for postmenopausal women (n = 5) and for women in the mid-follicular (n = 5) and mid-luteal (n = 5) phases of the menstrual cycle. A single blood sample from each woman was divided into 2.5-ml aliquots and stored at -70 degrees C, and sets of two aliquots were sent at monthly intervals to each of three laboratories (four for progesterone). Each aliquot was analyzed in duplicate. Thus, within each menstrual category, we were able to estimate the components of variance due to variation among women, variation among aliquots, variation among duplicate measurements, and variation among the 4 analysis days. Using the logarithm of assay measurements, we estimated the percentage of variance attributable to variation among women in each menstrual category, 100 rho, is the estimated intraclass correlation. For each assay, 100 rho exceeded 90% for mid-follicular and mid-luteal women. For postmenopausal women, values of 100 rho exceed 84% for estrone in two laboratories. Values of 100 rho were lower for progesterone in postmenopausal women, although a value of 84% was estimated from one laboratory. These studies indicate that estrogen assays over a period of 3 months permit reliable comparisons among women in a given menstrual category. Progesterone measurements are likewise reliable for women in the mid-follicular and mid-luteal phases but somewhat less satisfactory for postmenopausal women. These assessments of variability pertain only to laboratory techniques and do not allow for secular variation in intra-woman hormone levels. Moreover, although these measurements tend to be reliable enough for making comparisons among women, estimates of coefficients of variation for estrogens are about 10% for mid-follicular and mid-luteal phase women and about 11-20% for postmenopausal women. Coefficients of variation for progesterone are about 10% for mid-luteal, 20% for mid-follicular, and 30% for postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896895

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  11 in total

1.  Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women.

Authors:  Troy J Kemp; Alfonso García-Piñeres; Roni T Falk; Sylviane Poncelet; Francis Dessy; Sandra L Giannini; Ana Cecilia Rodriguez; Carolina Porras; Rolando Herrero; Allan Hildesheim; Ligia A Pinto
Journal:  Vaccine       Date:  2008-05-19       Impact factor: 3.641

2.  Searching for blood DNA methylation markers of breast cancer risk and early detection.

Authors:  Montserrat García-Closas; Mitchell H Gail; Karl T Kelsey; Regina G Ziegler
Journal:  J Natl Cancer Inst       Date:  2013-04-11       Impact factor: 13.506

3.  Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry.

Authors:  Barbara J Fuhrman; Xia Xu; Roni T Falk; Cher M Dallal; Timothy D Veenstra; Larry K Keefer; Barry I Graubard; Louise A Brinton; Regina G Ziegler; Gretchen L Gierach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

4.  Measurement of sex steroid hormones in breast adipocytes: methods and implications.

Authors:  Roni T Falk; Elisabet Gentzschein; Frank Z Stanczyk; Louise A Brinton; Montserrat Garcia-Closas; Olga B Ioffe; Mark E Sherman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

5.  Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Anda M Vlad; Hui-Min Lin; Gina Mantia-Smaldone; Robin Laskey; Minjae Lee; Yan Lin; Nicole Donnellan; Marcia Klein-Patel; Ted Lee; Suketu Mansuria; Esther Elishaev; Raluca Budiu; Robert P Edwards; Xin Huang
Journal:  Clin Cancer Res       Date:  2013-01-29       Impact factor: 12.531

6.  A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability.

Authors:  Roni T Falk; Xia Xu; Larry Keefer; Timothy D Veenstra; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

7.  Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.

Authors:  R G Ziegler; S C Rossi; T R Fears; H L Bradlow; H Adlercreutz; D Sepkovic; P Kiuru; K Wahala; J B Vaught; J L Donaldson; R T Falk; C M Fillmore; P K Siiteri; R N Hoover; M H Gail
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

8.  An analytical approach to reduce between-plate variation in multiplex assays that measure antibodies to Plasmodium falciparum antigens.

Authors:  Rui Fang; Andrew Wey; Naveen K Bobbili; Rose F G Leke; Diane Wallace Taylor; John J Chen
Journal:  Malar J       Date:  2017-07-17       Impact factor: 2.979

9.  The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women.

Authors:  Andrew E Williams; Gertraud Maskarinec; Adrian A Franke; Frank Z Stanczyk
Journal:  BMC Womens Health       Date:  2002-12-23       Impact factor: 2.809

10.  Does place of birth influence endogenous hormone levels in Asian-American women?

Authors:  R T Falk; T R Fears; R N Hoover; M C Pike; A H Wu; A M Y Nomura; L N Kolonel; D W West; R G Ziegler
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.